Aerie Pharmaceuticals Inc

Ownership Transactions Reported by 16 Insiders

Location
4301 Emperor Boulevard, Suite 400, Durham, North Carolina

There are no Buy or Sell transactions made by insiders since 8/26/2023

Aerie Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas A. Mitro President and COO $1.24M Feb 7, 2022
David Hollander Chief R&D Officer $469K Feb 4, 2022
Gerald D. Cagle Director $377K Jun 17, 2021
Kathleen Mcginley CHRO & VP, Corp Services $366K Jan 30, 2022
Christopher Staten Interim CFO $331K Aug 14, 2021
John LaRocca General Counsel Nov 21, 2022
Peter Frederick Lang Chief Financial Officer Nov 21, 2022
Benjamin F. Mcgraw III Director Nov 21, 2022
Jeffrey Calabrese Vice President of Finance Nov 21, 2022
Raj Kannan Chief Executive Officer, Director Nov 21, 2022
Casey C. Kopczynski Chief Scientific Officer Nov 21, 2022
David W. Gryska Director Nov 21, 2022
Richard Croarkin Director Nov 21, 2022
Peter J. McDonnell Director Nov 21, 2022
Michael du Director Nov 21, 2022
Julie McHugh Director Nov 21, 2022

Recent Insider Transactions by Companies or Individuals for Aerie Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.